GSK CEO transition sees Emma Walmsley stepping down, with Luke Miels set to take over on 1 January 2026.
Browsing: Market & Financials
Market trends, financial performance, quarterly results, and investment insights from global pharma and biotech companies.
Cipla Q1 earnings beat forecast, leading to a 5% share increase on 10 September 2025.
Successful drug launches face challenges like market timing and product advantage. Learn how to overcome these with insights from Jason O’Neill.
GSK $30B investment aims to expand US manufacturing, countering global pricing challenges.
LB Pharmaceuticals IPO raises $285M, marking the first major biotech IPO since February, focusing on schizophrenia treatment.
Takeda appoints Rhonda Pacheco to lead its U.S. business, leveraging her experience with Zepbound’s launch.
Novo Nordisk layoffs affect 9,000 employees globally as part of restructuring to address obesity drug competition.
Merck cancels London lab plans, citing $1.3B investment issues and lack of UK government progress.
Gilead AI manufacturing hub breaks ground in US, creating over 3,000 jobs and boosting biopharma innovation.
Enveda Biosciences funding reaches $300M to develop drugs for immune and obesity conditions, including atopic dermatitis and asthma.